The role of phospholamban and GSK3 in regulating rodent cardiac SERCA function
- 1 October 2020
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 319 (4), C694-C699
- https://doi.org/10.1152/ajpcell.00318.2020
Abstract
Cardiac contractile function is largely mediated by the regulation of Ca2+ cycling throughout the lifespan. The sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) pump is paramount to cardiac Ca2+ regulation, and it is well established that SERCA dysfunction pathologically contributes to cardiomyopathy and heart failure. Phospholamban (PLN) is a well-known inhibitor of the SERCA pump and its regulation of SERCA2a - the predominant cardiac SERCA isoform - contributes significantly to proper cardiac function. Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase involved in several metabolic pathways and we and others have shown that it regulates SERCA function. In this minireview, we highlight the underlying mechanisms behind GSK3's regulation of SERCA function specifically discussing changes in SERCA2a and PLN expression, and its potential protection against oxidative stress. Ultimately, these recent findings that we discuss could have clinical implications in the treatment and prevention of cardiomyopathies and heart failure.Keywords
Funding Information
- Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
This publication has 52 references indexed in Scilit:
- Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathyNetherlands Heart Journal, 2013
- Is the safety of lithium no longer in the balance?The Lancet, 2012
- GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic StrokeFrontiers in Molecular Neuroscience, 2011
- Protective effects of Hsp70 on the structure and function of SERCA2a expressed in HEK-293 cells during heat stressAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Normalization of Lithium-Induced Hypercalcemia and Hyperparathyroidism With Cinacalcet HydrochlorideAmerican Journal of Kidney Diseases, 2006
- Cyclic GMP-dependent Protein Kinase Regulates CCAAT Enhancer-binding Protein β Functions through Inhibition of Glycogen Synthase Kinase-3Online Journal of Public Health Informatics, 2005
- Phospholamban: a crucial regulator of cardiac contractilityNature Reviews Molecular Cell Biology, 2003
- Transgenic overexpression of the sarcoplasmic reticulum Ca 2+ ATPase improves reticular Ca 2+ handling in normal and diabetic rat heartsThe FASEB Journal, 2002
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995